Skip to content

Longevity

SS-20

InjectableEvidence CEvery day
Half-life
2hours
Typical vial
5 / 10mg
Research amounts
1–5mg

per administration

Common schedule
Every day
Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded60units dialled
Concentration
1.67mg/mL
Volume per draw
0.6mL
Units to dial
60
Doses per cartridge
5

Vial label

Copy this into your label printer.

Published research contexts for SS-20 describe 15 mg per administration. Descriptive only, not a recommendation.

Not characterized in humans; assumed similar to the related Szeto–Schiller peptides, so read as order-of-magnitude only.

A Szeto–Schiller mitochondrial-targeted peptide related to SS-31 (elamipretide); evidence is preclinical and no human study fixes an amount or schedule, so the figures are not trial-established and no schedule table is shown.

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
10hours

About five half-lives

Administrations
7/ week

Where these numbers come from

  • Szeto–Schiller peptide preclinical literatureSS-20 is characterized in animal and cell models of mitochondrial function; human dosing is not established.

Next steps